IL-6, albeit initially recognized as a pro-inflammatory cytokine28,44, has recently been shown to stimulate alternative Mφ activation, a well-known process associated with anti-inflammatory immunosuppressive functions, in diabetic and obesity conditions26,27. The gene discussed is IL6; the disease is obesity due to melanocortin 4 receptor deficiency.